Table 3.
List of gene ontology terms for predicted targets of differentially expressed miRNAs.
| GO ID | GO Terms | No. of Genes | p-Value |
|---|---|---|---|
| KEGG:04010 | MAPK signaling pathway | 53 | <0.001 |
| KEGG:04066 | HIF-1 signaling pathway | 32 | <0.001 |
| KEGG:05230 | Central carbon metabolism in cancer | 20 | <0.001 |
| KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 24 | <0.001 |
| KEGG:04151 | PI3K-Akt signaling pathway | 56 | <0.001 |
| KEGG:04210 | Apoptosis | 30 | <0.001 |
| KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 32 | <0.001 |
| KEGG:04668 | TNF signaling pathway | 27 | <0.001 |
| KEGG:04722 | Neurotrophin signaling pathway | 32 | <0.001 |
| KEGG:04933 | AGE-RACE signaling pathway in diabetic complications | 28 | <0.001 |
| KEGG:05200 | Pathways in cancer | 96 | <0.001 |
| KEGG:05205 | Proteoglycans in cancer | 48 | <0.001 |
| KEGG:05206 | microRNAs in cancer | 76 | <0.001 |
| KEGG:05211 | Renal cell carcinoma | 20 | <0.001 |
| KEGG:04068 | FoxO signaling pathway | 36 | <0.001 |
| KEGG:05215 | Prostate cancer | 35 | <0.001 |
| KEGG:05161 | Hepatitis B | 45 | <0.001 |
| KEGG:05162 | Measles | 32 | <0.001 |
| KEGG:05169 | EBV infection | 40 | <0.001 |
| KEGG:05220 | Chronic myeloid leukemia | 27 | <0.001 |
| KEGG:05222 | Small cell lung cancer | 26 | <0.001 |
| KEGG:04218 | Cellular senescence | 36 | <0.001 |
| KEGG:05163 | Human cytomegalovirus infection | 42 | <0.001 |
| KEGG:05210 | Colorectal cancer | 28 | <0.001 |
| KEGG:05212 | Pancreatic cancer | 27 | <0.001 |
| KEGG:05220 | Chronic myeloid leukemia | 27 | <0.001 |
| KEGG:05223 | Non-small cell lung cancer | 21 | <0.001 |
| KEGG:05224 | Breast cancer | 37 | <0.001 |
| KEGG:05225 | Hepatocellular carcinoma | 41 | <0.001 |
| KEGG:05226 | Gastric canner | 39 | <0.001 |
GO: gene ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes.